MERRIMACK PHARMACEUTICALS - ASSETS
Merrimack Pharmaceuticals - Assets (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of pancreas.
MERRIMACK PHARMACEUTICALS - ASSETS
Industry:
Biotechnology
Address:
Cambridge, Massachusetts, United States
Country:
United States
Status:
Active
More informations about "Merrimack Pharmaceuticals - Assets" on Search Engine
Merrimack - Crunchbase Company Profile & Funding
Merrimack Pharmaceuticals discovers, designs, and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. Their systems biology is to apply …See details»
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Jan 9, 2017 has entered into a definitive agreement to acquire global oncology assets from Merrimack. Pharmaceuticals (NASDAQ: MACK), including its key marketed …See details»
Investors | Merrimack Pharmaceuticals
Apr 30, 2024 The Investor Relations website contains information about Merrimack Pharmaceuticals's business for stockholders, potential investors, and financial analysts.See details»
Merrimack Pharmaceuticals - Assets - Drug pipelines, Patents, …
Explore Merrimack Pharmaceuticals - Assets with its drug pipeline, therapeutic area, technology platform, 7 news.See details»
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals, Inc. (the “Company”) is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive contingent milestone payments …See details»
SEC Filing | Merrimack Pharmaceuticals
Assets Current assets: Cash and cash equivalents $ 13,091 $ 14,203 Prepaid expenses and other current assets 537 480 Total current assets 13,628 14,683 Other assets 9 66 …See details»
Corporate Governance | Merrimack Pharmaceuticals
Corporate Governance. Merrimack’s board of directors sets high standards for the Company's employees, officers and directors. Implicit in this philosophy and …See details»
Press Releases | Merrimack Pharmaceuticals
Nov 2, 2023 CAMBRIDGE, Mass. --(BUSINESS WIRE)--Mar. 7, 2024-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today …See details»
Merrimack Pharmaceuticals Inc (MACK) Stock Price & News
Get the latest Merrimack Pharmaceuticals Inc (MACK) real-time quote, historical performance, charts, and other financial information to help you make more informed …See details»
Merrimack Pharmaceuticals Announces Notification of Plan to …
CAMBRIDGE, Mass., April 30, 2024--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") today announced that it has filed notice with NASDAQ …See details»
Merrimack - Funding, Financials, Valuation & Investors
Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.See details»
Merrimack Reports Second Quarter 2022 Financial Results
Aug 4, 2022 Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent …See details»
Merrimack Reports First Quarter 2023 Financial Results
May 4, 2023 CAMBRIDGE, Mass. -- (BUSINESS WIRE)--May 4, 2023-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [ (“Merrimack” or the “Company”)] today …See details»
Press Releases | Merrimack Pharmaceuticals
CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 4, 2023-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its first …See details»
Merrimack Pharmaceuticals Total Assets 2010-2023 | MACK
Merrimack Pharmaceuticals total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.See details»
Merrimack - Contacts, Employees, Board Members, Advisors
Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.See details»
Merrimack Pharmaceuticals, Inc. Announces Stockholder …
May 10, 2024 Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent …See details»
Merrimack Pharmaceuticals, Inc. Announces Stockholder …
May 10, 2024 Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent …See details»
2024-05-10 | NDAQ:MACK | Press Release | Merrimack …
May 10, 2024 ABOUT MERRIMACK. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to …See details»
Merrimack Pharmaceuticals, Inc. Announces Stockholder …
May 10, 2024 CAMBRIDGE, Mass. -- (BUSINESS WIRE)--May 10, 2024-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) announced …See details»